Jim Simons’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,100
Closed -$1.05M 3478
2025
Q4
$1.05M Buy
16,100
+4,000
+33% +$252K ﹤0.01% 2248
2025
Q3
$711K Sell
12,100
-11,200
-48% -$638K ﹤0.01% 2651
2025
Q2
$1.32M Buy
+23,300
New +$1.31M ﹤0.01% 2357
2024
Q4
Sell
-15,300
Closed -$995K 3732
2024
Q3
$995K Buy
+15,300
New +$978K ﹤0.01% 2450
2024
Q2
Sell
-15,800
Closed -$978K 3741
2024
Q1
$978K Buy
15,800
+7,800
+98% +$469K ﹤0.01% 2503
2023
Q4
$458K Buy
8,000
+3,500
+78% +$191K ﹤0.01% 2819
2023
Q3
$243K Buy
+4,500
New +$251K ﹤0.01% 3024
2023
Q2
Sell
-10,000
Closed -$546K 4090
2023
Q1
$546K Sell
10,000
-500
-5% -$27.4K ﹤0.01% 2838
2022
Q4
$596K Buy
10,500
+4,500
+75% +$248K ﹤0.01% 2851
2022
Q3
$304K Buy
+6,000
New +$324K ﹤0.01% 3205
2022
Q1
Sell
-23,500
Closed -$1.41M 4279
2021
Q4
$1.41M Buy
23,500
+12,000
+104% +$686K ﹤0.01% 2411
2021
Q3
$635K Buy
+11,500
New +$658K ﹤0.01% 2784
2020
Q1
Sell
-5,000
Closed -$216K 3616
2019
Q4
$216K Buy
+5,000
New +$202K ﹤0.01% 3176

Other funds holding IYH

Jim Simons's IYH Position: Q1 2026 in Review

Jim Simons sold out of iShares US Healthcare ETF (IYH) in Q1 2026, closing a stake of 16,100 shares — an estimated $1.05M sold.

Jim Simons first reported a position in IYH in Q4 2019 and held it in 13 quarters. The position peaked at $1.41M in Q4 2021. 514 funds tracked by Wall St. Rank hold IYH as of Q1 2026.

  • Jim Simons reported no remaining iShares US Healthcare ETF position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 16,100 iShares US Healthcare ETF shares in Q1 2026, an estimated $1.05M.
  • Jim Simons first reported a position in iShares US Healthcare ETF in Q4 2019 and held it in 13 quarters.
  • Jim Simons's iShares US Healthcare ETF position peaked at $1.41M in Q4 2021.
  • 514 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.